Shasun Pharmaceuticals Ltd approves conversion of warrants

The Board of Directors of Shasun Pharmaceuticals Ltd at its meeting held on June 08, 2015, has approved the conversion of 71,00,000 convertible warrants into equity shares of the Company, which were issued on May 30, 2014 to M/s. Sequent Scientific Limited, Mumbai, on preferential basis at a price of Rs 110 per share including premium of Rs 108 per share.

Shares of SHASUN PHARMACEUTICALS LTD. was last trading in BSE at Rs.351.9 as compared to the previous close of Rs. 359.5. The total number of shares traded during the day was 12443 in over 500 trades.

The stock hit an intraday high of Rs. 361 and intraday low of 348.5. The net turnover during the day was Rs. 4382962.

Source : Equity Bulls

Keywords